Ilex Medical

Ilex Medical FCF per Share

The Free Cash Flow per Share of Ilex Medical (ILX.TA) as of Oct 22, 2026 is 2.53 ILS. In the previous year, Free Cash Flow per Share was 3.67 ILS — a change of -31.15% (lower).

FCF per Share

2.53ILS

YoY

-31.15%

Last updated:

Free Cash Flow per Share of Ilex Medical is 2023 2.53 ILS. Free Cash Flow per Share of Ilex Medical was 2022 3.67 ILS. It decreases by -31.15% lower compared to the previous year.

The Ilex Medical FCF per Share history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

FCF per Share
Date
FCF per Share
Jan 1, 2016
-0.19 ILS
Jan 1, 2017
5.47 ILS
Jan 1, 2018
3.40 ILS
Jan 1, 2019
5.34 ILS
Jan 1, 2020
12.67 ILS
Jan 1, 2021
20.21 ILS
Jan 1, 2022
3.67 ILS
Jan 1, 2023
2.53 ILS
The Ilex Medical FCF per Share history
YEARFCF per ShareYoY
2.53ILS-31.15%
3.67ILS-81.84%
20.21ILS+59.43%
12.67ILS+137.18%
5.34ILS+57.24%
3.40ILS-37.82%
5.47ILS-2,946.34%
-0.19ILS-109.65%
1.99ILS-70.69%
6.79ILS—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Ilex Medical Stock analysis

What does Ilex Medical do? Ilex Medical Ltd supplies in vitro diagnostic equipment and laboratory management software, targeting healthcare providers and laboratories. The company offers nucleic acid testing (NAT) blood screening solutions, cancer screening products, retro virus load monitoring, TB and STD testing systems, and blood sugar monitoring devices. Its subsidiaries include Ilex South Africa, Orsyx-LIS, Ilex BioTech Ltd, and Medtechnica Ltd, which support its diagnostic equipment and software distribution. Healthcare facilities and diagnostic laboratories purchase these products for clinical testing and patient management. Ilex Medical Ltd's revenue streams come from selling diagnostic equipment, reagent systems, and laboratory information systems (LIS) to healthcare institutions. The firm's NAT blood screening solutions and infectious disease testing systems are key products for blood banks and public health labs. Subsidiaries like Orsyx-LIS provide specialized laboratory management software, enhancing the company's offerings in the diagnostic software segment. Hospitals and clinics rely on these solutions for efficient diagnostic workflows. The company serves segments including hospitals, blood banks, public health laboratories, and clinics focused on infectious disease management. Products such as cancer screening tools and retro virus load systems are sold to specialized medical facilities. Ilex South Africa and Medtechnica Ltd extend the company's reach in regional markets, supporting localized sales and service. Diagnostic software from Orsyx-LIS is integrated into laboratory workflows for improved data management. Ilex Medical is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Ilex Medical stock

Free Cash Flow per Share of Ilex Medical is 2.53 ILS in 2023.

Free Cash Flow per Share of Ilex Medical changed from 3.67 ILS to 2.53 ILS, representing a -31.15% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Free Cash Flow per Share Ilex Medical since 2006 – with annual values, charts, and detailed analysis.

FCF per share measures the free cash flow allocated to each outstanding share. It is a key metric for assessing shareholder value creation.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Cash Flow — Ilex Medical

All Key Metrics — Ilex Medical